Bal Pharma - BALPHARMA, 524824 corporate action history

Bal Pharma Ltd.

NSE: BALPHARMA | BSE: 524824

Strong Performer, Under Radar

Download real time

82.03 -3.10 (-3.64%)

26.22% Fall from 52W High

10,546

NSE+BSE Volume

NSE 22 May, 2026 3:31 PM (IST)

Board Meeting

The next board meeting for Bal Pharma is on 27 May 2026 for the purpose of Audited Results, Final Dividend & ESOP See details

Bal Pharma Bonus history

Bal Pharma has not announced any bonus since Jan 1, 2000.

See all forthcoming Bonus and Splits

Bal Pharma Split history

Bal Pharma has not split the face value of the share since Jan 1, 2000.

See all forthcoming Bonus and Splits

Dividend history for Bal Pharma

Bal Pharma has declared 18 dividends since Sept. 1, 2004.

In the past 12 months, Bal Pharma has declared an equity dividend amounting to ₹1.20 per share.

At the current share price of ₹82.0300, Bal Pharma's dividend yield is 1.46%.

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
18 Sep 2025	1.200	FINAL	18 Sep 2025	Equity Share
18 Sep 2024	1.200	FINAL	-	Equity Share
18 Sep 2023	1.000	FINAL	-	Equity Share
13 Sep 2022	1.000	FINAL	-	Equity Share
16 Sep 2021	1.000	FINAL	-	Equity Share
17 Sep 2019	1.000	FINAL	-	Equity Share
14 Sep 2018	1.000	FINAL	-	Equity Share
14 Sep 2017	1.000	FINAL	-	Equity Share
15 Sep 2016	1.000	FINAL	-	Equity Share
15 Sep 2015	1.000	FINAL	-	Equity Share
12 Sep 2014	1.000	FINAL	-	Equity Share
12 Sep 2013	0.750	FINAL	-	Equity Share
17 Sep 2009	0.750	FINAL	-	Equity Share
09 Sep 2008	1.000	FINAL	-	Equity Share
07 Sep 2007	0.750	FINAL	-	Equity Share
07 Sep 2006	0.750	FINAL	-	Equity Share
09 Sep 2005	0.750	FINAL	-	Equity Share
01 Sep 2004	1.500	FINAL	-	Equity Share

VIEW MORE

See all forthcoming dividends Check out stocks with top dividend.

Board Meetings - Bal Pharma

The next board meeting for Bal Pharma is on 27 May 2026 for the purpose of Audited Results, Final Dividend & ESOP

Ex-Date	Purpose	Notes
27 May 2026	Audited Results, Final Dividend & ESOP	-
11 Feb 2026	Quarterly Results	-
12 Nov 2025	Quarterly Results	-
11 Aug 2025	Quarterly Results, ESOP & A.G.M.	-
29 May 2025	Audited Results & Dividend	-
13 Feb 2025	Quarterly Results & Fund Raising	-
14 Nov 2024	Quarterly Results	-
12 Aug 2024	Quarterly Results, ESOP & A.G.M.	-
28 May 2024	Audited Results & Final Dividend	-
12 Feb 2024	Quarterly Results	-

See all Board Meetings for Bal Pharma

Rights history for Bal Pharma

Bal Pharma issued rights 1 time since April 7, 2005. Bal Pharma had last issued Rights shares of ₹10.0/- in the ratio of 3.0:5.0 @ premium of ₹20.0/- on April 7, 2005.

Ex-Date	Ratio	Face Value	Premium	Record Date
07 Apr 2005	3.0:5.0	10.0	20.0	15 Apr 2005

See all Rights History for Bal Pharma

Is Bal Pharma Ltd. worth buying?

56 Votes:

Buy 75.0%

Sell 12.5%

Hold 12.5%